Raudondvario klinika - Company finances
|
EUR
|
2018
From: 2018-05-03
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 0 | - | 103,028 | 524,754 | 675,104 | 816,934 | 943,402 | 1,153,976 |
| Profit before tax | - | - | -17,867 | 30,710 | 79,162 | 47,179 | 28,167 | 37,865 |
| Net profit | 0 | -5,043 | -17,867 | 28,509 | 67,219 | 46,771 | 28,029 | 31,899 |
| Equity | 2,500 | -2,543 | -20,410 | 8,099 | 75,318 | 131,992 | 160,021 | 197,885 |
| Liabilities | 0 | 118,072 | 156,706 | 123,406 | 122,518 | 86,243 | 79,829 | 99,704 |
| Non-current assets | 0 | 110,012 | 106,620 | 87,223 | 83,649 | 64,039 | 60,318 | 58,276 |
| Current assets | 2,500 | 56,017 | 88,647 | 119,763 | 127,285 | 154,196 | 180,596 | 254,022 |
| Total assets | 2,500 | 166,029 | 195,267 | 206,986 | 210,934 | 218,235 | 240,914 | 312,298 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 114,420 | 137,808 | 179,176 |
| Social insurance contributions | - | - | - | - | - | 131,571 | 162,901 | 219,067 |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | - | - | +409.3% | +28.7% | +21.0% | +15.5% | +22.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.0% | -3.0% | -9.2% | 13.8% | 31.9% | 21.4% | 11.6% | 10.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 0.0% | - | - | 352.0% | 89.2% | 35.4% | 17.5% | 16.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | - | -17.3% | 5.4% | 10.0% | 5.7% | 3.0% | 2.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | -17.3% | 5.9% | 11.7% | 5.8% | 3.0% | 3.3% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | 15.2 | 1.6 | 0.7 | 0.5 | 0.5 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | 7,825 | 11,770 | 12,599 | 13,965 | 16,722 | 18,866 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Raudondvario klinika - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-08-19 | 2025-08-29 | 12.39 |
| 2025-07-24 | 2025-08-11 | 12.39 |
| 2025-07-16 | 2025-07-23 | 12.29 |
| 2025-06-17 | 2025-07-14 | 12.38 |
| 2025-06-11 | 2025-06-11 | 0.11 |
| 2025-06-08 | 2025-06-09 | 0.11 |
| 2025-05-16 | 2025-06-04 | 0.11 |
| 2022-05-18 | 2022-05-25 | 128.93 |
| 2022-05-17 | 2022-05-17 | 6625.46 |
| 2022-03-16 | 2022-03-16 | 6332.90 |
Raudondvario klinika - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-02-27 | 2026-02-27 | 0.56 |
| 2026-02-21 | 2026-02-26 | 161.4 |
| 2026-02-03 | 2026-02-03 | 308.4 |
| 2026-01-29 | 2026-02-02 | 308.0 |
| 2025-12-01 | 2025-12-23 | 1.44 |
| 2025-11-28 | 2025-11-30 | 4.3 |
| 2025-11-02 | 2025-11-21 | 4.3 |
| 2025-10-30 | 2025-11-01 | 4.4 |
| 2025-10-04 | 2025-10-21 | 828.0 |
| 2025-04-28 | 2025-04-28 | 977.06 |
| 2025-04-02 | 2025-04-27 | 0.06 |
| 2025-02-16 | 2025-02-17 | 95.82 |
| 2024-11-28 | 2024-11-29 | 12.94 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Raudondvario klinika, UAB (company code 304836782) is a Private Limited Liability Company engaged in general medical practice activities. In 2025, the company generated revenue of EUR 1.15 million and net profit of EUR 31.9 thousand, with a profit margin of 2.8%. Revenue increased by 22.3% year on year and by 41.3% over two years, showing a steady upward trajectory from EUR 816.9 thousand in 2023 to EUR 943.4 thousand in 2024 and EUR 1.15 million in 2025. Net profit moved from EUR 46.8 thousand in 2023 to EUR 28.0 thousand in 2024 and EUR 31.9 thousand in 2025, indicating some fluctuation despite stronger sales growth. At the end of 2025, total assets stood at EUR 312.3 thousand, equity at EUR 197.9 thousand and liabilities at EUR 99.7 thousand. Key balance sheet ratios were solid, including an equity ratio of 63.4% and debt-to-equity of 0.50. The company also reported ROE of 16.1%, ROA of 10.2% and asset turnover of 3.70x. Revenue per employee was EUR 18.9 thousand, while profit per employee was EUR 523.